MWNA
BSX icon

Marshall Wace North America’s Boston Scientific BSX Stock Holding History

Marshall Wace North America’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$236M Sell
5,446,332
-413,523
-7% -$18.3M 1.01% 11
2021
Q2 		$251M Buy
5,859,855
+1,089,462
+23% +$45.8M 1.04% 11
2021
Q1 		$184M Buy
4,770,393
+180,286
+4% +$6.82M 0.76% 17
2020
Q4 		$165M Buy
4,590,107
+693,756
+18% +$25M 0.74% 18
2020
Q3 		$149M Sell
3,896,351
-1,357,198
-26% -$52.3M 0.95% 18
2020
Q2 		$184M Buy
5,253,549
+166,825
+3% +$6.01M 1.22% 9
2020
Q1 		$166M Sell
5,086,724
-2,303,173
-31% -$90M 1.26% 11
2019
Q4 		$334M Sell
7,389,897
-1,263,791
-15% -$52.9M 1.61% 3
2019
Q3 		$352M Buy
8,653,688
+218,273
+3% +$9.25M 2% 4
2019
Q2 		$363M Sell
8,435,415
-567,255
-6% -$21.8M 2.25% 1
2019
Q1 		$346M Buy
9,002,670
+2,494,598
+38% +$95.3M 2.44% 2
2018
Q4 		$230M Sell
6,508,072
-825,324
-11% -$29.9M 2.23% 5
2018
Q3 		$282M Sell
7,333,396
-1,615,233
-18% -$56.4M 1.94% 4
2018
Q2 		$293M Sell
8,948,629
-2,567,644
-22% -$77.4M 1.65% 2
2018
Q1 		$315M Buy
11,516,273
+1,205,496
+12% +$32.8M 1.58% 3
2017
Q4 		$256M Buy
10,310,777
+7,929,843
+333% +$219M 1.41% 5
2017
Q3 		$69M Buy
2,380,934
+197,751
+9% +$5.46M 0.44% 40
2017
Q2 		$61.1M Sell
2,183,183
-3,811,174
-64% -$101M 0.45% 49
2017
Q1 		$150M Buy
+5,994,357
New +$146M 1.18% 6

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Marshall Wace North America's BSX Position: Q3 2021 in Review

Marshall Wace North America reduced its Boston Scientific (BSX) stake by 7.1% in Q3 2021, selling an estimated $18.3M and leaving 5,446,332 shares worth $236M. The position accounts for 1.01% of the portfolio, ranked #11.

Marshall Wace North America first reported a position in BSX in Q1 2017 and has held it in 19 quarters since. The position peaked at $363M in Q2 2019. 879 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

  • Marshall Wace North America held 5,446,332 shares of Boston Scientific worth $236M as of Q3 2021.
  • Marshall Wace North America sold 413,523 Boston Scientific shares in Q3 2021, an estimated $18.3M.
  • Boston Scientific made up 1.01% of Marshall Wace North America's portfolio in Q3 2021, its #11 holding.
  • Marshall Wace North America first reported a position in Boston Scientific in Q1 2017 and has held it in 19 quarters since.
  • Marshall Wace North America's Boston Scientific position peaked at $363M in Q2 2019.
  • 879 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.